Deke Medtech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Deke Medtech General Information

Description

Researcher and producer of hydrogel intended for myocardial repair. The company focuses on non-pharmacological treatments, develops the formulation of hydrogel, optimizes treatment protocols, and develops minimally invasive procedures and devices, enabling patients with treatments for end-stage heart failure including cardiac resynchronization pacing (CRT), left ventricular assist devices (LVADs) and heart transplantation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 340, 3/F, Building 2
  • No. 88, Jiangling Road, Binjiang District
  • Hangzhou, Zhejiang
  • China
+86 135
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Corporate Office
  • Room 340, 3/F, Building 2
  • No. 88, Jiangling Road, Binjiang District
  • Hangzhou, Zhejiang
  • China
+86 135

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Deke Medtech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 14-Feb-2024 Completed Generating Revenue
To view Deke Medtech’s complete valuation and funding history, request access »

Deke Medtech Patents

Deke Medtech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4458302-A1 Adaptive guidance device and transcatheter treatment system Pending 31-Dec-2021
EP-4458302-A4 Adaptive guidance device and transcatheter treatment system Pending 31-Dec-2021
WO-2023125572-A1 Adaptive guidance device and transcatheter treatment system Inactive 31-Dec-2021
US-20240350772-A1 Adaptive guiding device and transcatheter treatment system Pending 31-Dec-2021
EP-4458291-A1 Sleeve, injection device, injection system, ablation device and ablation system Pending 31-Dec-2021 A61B18/1492
To view Deke Medtech’s complete patent history, request access »

Deke Medtech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Qiming Venture Partners Venture Capital Minority
Tasly Capital Corporate Venture Capital Minority
To view Deke Medtech’s complete investors history, request access »

Deke Medtech Investments (2)

Deke Medtech’s most recent deal was a Joint Venture with Joint Venture (Deke Medtech / Metronom Health / Ascendum Capital). The deal was made on 18-May-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Deke Medtech / Metronom Health / Ascendum Capital) 18-May-2021 Joint Venture Monitoring Equipment
Hangzhou Dinova Accelerator/Incubator Therapeutic Devices
To view Deke Medtech’s complete investments history, request access »

Deke Medtech FAQs

  • When was Deke Medtech founded?

    Deke Medtech was founded in 2017.

  • Where is Deke Medtech headquartered?

    Deke Medtech is headquartered in Hangzhou, China.

  • What industry is Deke Medtech in?

    Deke Medtech’s primary industry is Medical Supplies.

  • Is Deke Medtech a private or public company?

    Deke Medtech is a Private company.

  • What is Deke Medtech’s current revenue?

    The current revenue for Deke Medtech is .

  • Who are Deke Medtech’s investors?

    Qiming Venture Partners and Tasly Capital have invested in Deke Medtech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process